Spots Global Cancer Trial Database for germ cell tumor
Every month we try and update this database with for germ cell tumor cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Role of Axumin PET Scan in Germ Cell Tumor | NCT03426865 | Testis Cancer Germ Cell Tumor Testicular Canc... Germ Cell Tumor... Germ Cell Tumor... Testicular Neop... Testicular Germ... Testicular Yolk... Testicular Chor... Testicular Dise... Germ Cell Cance... Germ Cell Neopl... Germ Cell Cance... | Axumin PET scan | 18 Years - | University of Texas Southwestern Medical Center | |
| Memantine for Prevention of Cognitive Late Effects in Pediatric Patients Receiving Cranial Radiation Therapy for Localized Brain Tumors | NCT03194906 | Glioma of Brain Craniopharyngio... Ependymoma Germ Cell Tumor | Memantine Placebo Cognitive Asses... | 6 Years - 21 Years | St. Jude Children's Research Hospital | |
| Molecular Epidemiology of Pediatric Germ Cell Tumors | NCT05564026 | Germ Cell Tumor Germinoma Teratoma Embryonal Carci... Yolk Sac Tumor Choriocarcinoma Mixed Germ Cell... Late Effects Pediatric Germ ... | Questionnaire A... Tumor Specimen ... Germline DNA Sa... Blood Sample Co... | - | Children's Oncology Group | |
| A Study of miRNA 371 in Patients With Germ Cell Tumors | NCT04435756 | Germ Cell Tumor Metachronous Ma... Seminoma Stage I Testicu... Stage IA Testic... Stage IB Testic... Stage IS Testic... | Biomarker Analy... Blood Product C... | 18 Years - | SWOG Cancer Research Network | |
| Robot-assisted ICG-guided Sentinel Node Biopsy in Testicular Cancer | NCT06133543 | Germ Cell Tumor Seminoma Nonseminomatous... | Robot-assisted ... | 18 Years - 99 Years | Heinrich-Heine University, Duesseldorf | |
| Trial of Gemcitabine, Cisplatin, and Ifosfamide in Patients With Relapsed Non-Seminomatous Germ-Cell Tumors | NCT00127049 | Germ Cell Tumor | gemcitabine, if... | 16 Years - | Gustave Roussy, Cancer Campus, Grand Paris | |
| Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors | NCT00179816 | Ewing's Sarcoma Soft Tissue Sar... Hepatoblastoma Hodgkin's Disea... Germ Cell Tumor | High-Dose Chemo... | - 21 Years | Ann & Robert H Lurie Children's Hospital of Chicago | |
| Salvage Chemotherapy for Poor Prognosis Germ Cell Tumors | NCT01966913 | Germ Cell Tumor | Bevacizumab ICE chemotherap... | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| CpG 7909 in Treating Patients Who Have Undergone Autologous Stem Cell Transplant | NCT00369291 | Germ Cell Tumor Leukemia Lymphoma Multiple Myelom... | keyhole limpet ... tetanus toxoid | 18 Years - | Masonic Cancer Center, University of Minnesota | |
| Symptom Management for YA Cancer Survivors | NCT04035447 | Cancer Young Adult Pain Psychological D... Fatigue Breast Cancer Melanoma Hematologic Can... Germ Cell Tumor Endocrine Cance... | Behavioral Symp... | 18 Years - 39 Years | Duke University | |
| Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System | NCT04743310 | Central Nervous... | tozuleristide Canvas imaging ... Surgical resect... | 18 Years - | Cedars-Sinai Medical Center | |
| A Phase II Trial of Cabozantinib With Patients With Refractory GCTs | NCT04876456 | Germ Cell Tumor Seminoma Non-seminomatou... Ovarian Germ Ce... | Cabozantinib | - | Indiana University | |
| A Study of DS-9606a in Patients With Advanced Solid Tumors | NCT05394675 | Advanced Cancer Metastatic Canc... Ovarian Cancer Germ Cell Tumor | DS-9606a | 18 Years - | Daiichi Sankyo | |
| Phase II Study of Cisplatin Plus Epirubicin Salvage Chemo in Refractory Germ Cell Tumors | NCT00198172 | Germ Cell Tumor | Cisplatin plus ... | 15 Years - | Indiana University | |
| Establishing Prospective Mediastinal Tumor Database of PUMCH | NCT06421805 | Thymic Epitheli... Teratoma Thymic Cyst Retrosternal Go... Germ Cell Tumor Lymphoma Schwannoma | - | Peking Union Medical College Hospital | ||
| Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors | NCT02375204 | Germ Cell Tumor Teratoma Choriocarcinoma Germinoma Mixed Germ Cell... Yolk Sac Tumor Childhood Terat... Malignant Germ ... Extragonadal Se... Non-seminomatou... Seminoma | paclitaxel ifosfamide cisplatin pegylated G-CSF G-CSF carboplatin etoposide phosp... stem cell reinf... | 14 Years - | Alliance for Clinical Trials in Oncology | |
| Disulfiram and Cisplatin in Refractory TGCTs. | NCT03950830 | Germ Cell Tumor | Disulfiram | 18 Years - | National Cancer Institute, Slovakia | |
| MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors | NCT02076906 | Relapsed Pediat... Refractory Pedi... Rhabdomyosarcom... Ewing Sarcoma Osteosarcoma Neuroblastoma Wilms Tumor Hepatic Tumor Germ Cell Tumor Desmoid Tumor | Magnetic Resona... | - 30 Years | Children's National Research Institute | |
| Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 2021 WHO Classification | NCT05259605 | Glioma Glioneuronal Tu... Choroid Plexus ... Pineal Tumors Germ Cell Tumor Tumor of the Se... Diffuse Midline... Ependymoma Embryonal Tumor Pineal Tumor Hemangiopericyt... Hemangioblastom... Melanocytic Tum... | Observational | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Phase II Study of Cisplatin Plus Epirubicin Salvage Chemo in Refractory Germ Cell Tumors | NCT00198172 | Germ Cell Tumor | Cisplatin plus ... | 15 Years - | Indiana University | |
| Study of Oxaliplatin Plus Bevacizumab in Germ Cell Tumor Patients | NCT00393861 | Neoplasms, Germ... | Bevacizumab and... | 18 Years - | Indiana University | |
| A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas | NCT01625351 | Ewing Sarcoma Gastrointestina... Germ Cell Tumor Hepatic Tumor Lymphoma Wilms Tumor Rhabdoid Tumor Clear Cell Carc... Renal Cell Carc... Melanoma Neuroblastoma Rhabdomyosarcom... Non-rhabdomyosa... | alemtuzumab fludarabine sirolimus Busulfan melphalan stem cells CliniMACS | 2 Years - 21 Years | St. Jude Children's Research Hospital | |
| Study Evaluating the Impact of Short Message Service on Compliance With Surveillance of Patients With Germ-cell Tumors | NCT03868176 | Follow-up Compliance, Pat... Text Messaging Germ Cell Tumor | short message s... | 18 Years - | Centre Hospitalier Universitaire de Besancon | |
| High-dose Chemotherapy as Second-line Drug Therapy for Relapsed Germ Cell Tumors | NCT06418789 | Germ Cell Tumor | High-dose chemo... | 18 Years - | N.N. Petrov National Medical Research Center of Oncology | |
| High-dose Chemotherapy as Second-line Drug Therapy for Relapsed Germ Cell Tumors | NCT06418789 | Germ Cell Tumor | High-dose chemo... | 18 Years - | N.N. Petrov National Medical Research Center of Oncology | |
| Durvalumab Alone or With Tremelimumab in Refractory Germ Cell Tumors | NCT03081923 | Germ Cell Tumor | Durvalumab Tremelimumab | 18 Years - 75 Years | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| Effect and Safety of Ocoxin Oral Solution on the Quality of Life of Paediatric Patients With Advanced Stage Solid Tumours | NCT06363201 | Advanced Cancer Advanced Solid ... Lymphoma, Hodgk... Central Nervous... Sarcoma Germ Cell Tumor Pediatric Cance... | Ocoxin Oral sol... | 7 Years - 18 Years | Catalysis SL | |
| Effect and Safety of Ocoxin Oral Solution on the Quality of Life of Paediatric Patients With Advanced Stage Solid Tumours | NCT06363201 | Advanced Cancer Advanced Solid ... Lymphoma, Hodgk... Central Nervous... Sarcoma Germ Cell Tumor Pediatric Cance... | Ocoxin Oral sol... | 7 Years - 18 Years | Catalysis SL | |
| SerUm and Plasma MicroRNAs in Malignant Ovarian gERm Cell Tumours | NCT06329323 | Germ Cell Ovari... Germ Cell Tumor Germ Cell Cance... Germ Cell Neopl... Ovary Cancer Ovary Neoplasm Ovarian Cancer Ovarian Neoplas... | Blood test Pathology speci... | 16 Years - | Imperial College London | |
| Morbidity, Long-term Side Effects and Quality of Life in Germ-cell Tumor Long Survivors Treated With High-dose Chemotherapy and Autologous Stem Cell Transplant | NCT05889585 | Germ Cell Tumor | 18 Years - | Gustave Roussy, Cancer Campus, Grand Paris | ||
| Genetic and Molecular Risk Profiles of Pediatric Malignant Brain Tumors in China | NCT05672043 | Medulloblastoma Central Nervous... Ependymoma Germ Cell Tumor Glioma Brain Tumor, Pe... | 0 Years - 18 Years | Beijing Tiantan Hospital | ||
| Study of Brentuximab Vedotin And Bevacizumab In Refractory CD-30 Positive Germ Cell Tumors | NCT02988843 | Germ Cell Tumor | Brentuximab Ved... Bevacizumab | 18 Years - | Masonic Cancer Center, University of Minnesota | |
| Study of Genistein in Pediatric Oncology Patients (UVA-Gen001) | NCT02624388 | Lymphoma Childhood Lymph... Solid Tumor Childhood Solid... Neuroblastoma Ewing Sarcoma Hodgkin Lymphom... Non-Hodgkin Lym... Rhabdomyosarcom... Soft Tissue Sar... Medulloblastoma Germ Cell Tumor Wilms Tumor Brain Neoplasms Medulloblastoma... Neuroectodermal... | Genistein Placebo | 1 Year - 21 Years | University of Virginia | |
| CD30 CAR for CD30+ NSGCT | NCT05634785 | Germ Cell Tumor Nonseminomatous... | ATLCAR.CD30 Cel... Cyclophosphamid Fludarabine | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Maintenance Oral Etoposide or Observation Following High-dose Chemo for GCT | NCT04804007 | Germ Cell Tumor Non-seminomatou... Ovarian Germ Ce... | Etoposide | 18 Years - | Indiana University | |
| B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults | NCT04483778 | Pediatric Solid... Germ Cell Tumor Retinoblastoma Hepatoblastoma Wilms Tumor Rhabdoid Tumor Carcinoma Osteosarcoma Ewing Sarcoma Rhabdomyosarcom... Synovial Sarcom... Clear Cell Sarc... Malignant Perip... Desmoplastic Sm... Soft Tissue Sar... Neuroblastoma Melanoma | second generati... second generati... Pembrolizumab | 0 Years - 26 Years | Seattle Children's Hospital | |
| Salvage Chemotherapy for Poor Prognosis Germ Cell Tumors | NCT01966913 | Germ Cell Tumor | Bevacizumab ICE chemotherap... | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| First Line TIP in Poor Prognosis TGCTs. | NCT02414685 | Germ Cell Tumor | Paclitaxel Ifosfamide Cisplatin | 18 Years - | National Cancer Institute, Slovakia | |
| Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors | NCT02375204 | Germ Cell Tumor Teratoma Choriocarcinoma Germinoma Mixed Germ Cell... Yolk Sac Tumor Childhood Terat... Malignant Germ ... Extragonadal Se... Non-seminomatou... Seminoma | paclitaxel ifosfamide cisplatin pegylated G-CSF G-CSF carboplatin etoposide phosp... stem cell reinf... | 14 Years - | Alliance for Clinical Trials in Oncology | |
| Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours | NCT02582697 | Germ Cell Tumor | Bleomycin (acti... Etoposide Cisplatin Pegylated G-CSF... Filgrastim | 11 Years - 45 Years | University of Sydney | |
| Molecular Epidemiology of Pediatric Germ Cell Tumors | NCT05564026 | Germ Cell Tumor Germinoma Teratoma Embryonal Carci... Yolk Sac Tumor Choriocarcinoma Mixed Germ Cell... Late Effects Pediatric Germ ... | Questionnaire A... Tumor Specimen ... Germline DNA Sa... Blood Sample Co... | - | Children's Oncology Group | |
| Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors | NCT02375204 | Germ Cell Tumor Teratoma Choriocarcinoma Germinoma Mixed Germ Cell... Yolk Sac Tumor Childhood Terat... Malignant Germ ... Extragonadal Se... Non-seminomatou... Seminoma | paclitaxel ifosfamide cisplatin pegylated G-CSF G-CSF carboplatin etoposide phosp... stem cell reinf... | 14 Years - | Alliance for Clinical Trials in Oncology | |
| Nab-paclitaxel in Combination With Gemcitabine for Pediatric Relapsed and Refractory Solid Tumors | NCT03507491 | Cancer | Gemcitabine Nab-paclitaxel | 6 Months - 30 Years | Emory University | |
| Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System | NCT04743310 | Central Nervous... | tozuleristide Canvas imaging ... Surgical resect... | 18 Years - | Cedars-Sinai Medical Center | |
| Effect and Safety of Ocoxin Oral Solution on the Quality of Life of Paediatric Patients With Advanced Stage Solid Tumours | NCT06363201 | Advanced Cancer Advanced Solid ... Lymphoma, Hodgk... Central Nervous... Sarcoma Germ Cell Tumor Pediatric Cance... | Ocoxin Oral sol... | 7 Years - 18 Years | Catalysis SL | |
| HSV G207 Alone or With a Single Radiation Dose in Children With Progressive or Recurrent Supratentorial Brain Tumors | NCT02457845 | Supratentorial ... Malignant Gliom... Glioblastoma Anaplastic Astr... PNET Cerebral Primit... Embryonal Tumor | G207 | 3 Years - 18 Years | University of Alabama at Birmingham | |
| Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors | NCT00179816 | Ewing's Sarcoma Soft Tissue Sar... Hepatoblastoma Hodgkin's Disea... Germ Cell Tumor | High-Dose Chemo... | - 21 Years | Ann & Robert H Lurie Children's Hospital of Chicago | |
| Proton Beam Radiation Therapy for Central Nervous System (CNS) Germ Cell Tumors | NCT01049230 | Germ Cell Tumor Central Nervous... | Proton Beam rad... | 3 Years - 25 Years | Massachusetts General Hospital | |
| Photodynamic Therapy (PDT) For Recurrent High Grade Gliomas | NCT01966809 | Brain Tumor, Re... | Photofrin photo... | 18 Years - | Medical College of Wisconsin | |
| Multidisciplinary Approach to Fatigue | NCT05502224 | Breast Cancer Germ Cell Tumor | Ergospirometry | 18 Years - 39 Years | Jules Bordet Institute | |
| Morbidity, Long-term Side Effects and Quality of Life in Germ-cell Tumor Long Survivors Treated With High-dose Chemotherapy and Autologous Stem Cell Transplant | NCT05889585 | Germ Cell Tumor | 18 Years - | Gustave Roussy, Cancer Campus, Grand Paris | ||
| Rolapitant Plus Olanzapine in Multiday Cisplatin Chemotherapy | NCT03960151 | Germ Cell Tumor | Rolapitant Palonosetron Olanzapine Dexamethasone | 18 Years - | Hoosier Cancer Research Network | |
| Trial of Gemcitabine, Cisplatin, and Ifosfamide in Patients With Relapsed Non-Seminomatous Germ-Cell Tumors | NCT00127049 | Germ Cell Tumor | gemcitabine, if... | 16 Years - | Gustave Roussy, Cancer Campus, Grand Paris | |
| Study of the Hypomethylating Drug Guadecitabine (SGI-110) Plus Cisplatin in Relapsed Refractory Germ Cell Tumors | NCT02429466 | Germ Cell Tumor Testis Cancer Testicular Canc... | Guadecitabine (... | 18 Years - | Indiana University | |
| Disulfiram and Cisplatin in Refractory TGCTs. | NCT03950830 | Germ Cell Tumor | Disulfiram | 18 Years - | National Cancer Institute, Slovakia | |
| Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 2021 WHO Classification | NCT05259605 | Glioma Glioneuronal Tu... Choroid Plexus ... Pineal Tumors Germ Cell Tumor Tumor of the Se... Diffuse Midline... Ependymoma Embryonal Tumor Pineal Tumor Hemangiopericyt... Hemangioblastom... Melanocytic Tum... | Observational | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Memantine for Prevention of Cognitive Late Effects in Pediatric Patients Receiving Cranial Radiation Therapy for Localized Brain Tumors | NCT03194906 | Glioma of Brain Craniopharyngio... Ependymoma Germ Cell Tumor | Memantine Placebo Cognitive Asses... | 6 Years - 21 Years | St. Jude Children's Research Hospital | |
| Photodynamic Therapy (PDT) for Recurrent Pediatric Brain Tumors | NCT01682746 | Brain Tumor, Re... | Photofrin (porf... | 6 Months - 18 Years | Medical College of Wisconsin | |
| Photodynamic Therapy (PDT) for Recurrent Pediatric Brain Tumors | NCT01682746 | Brain Tumor, Re... | Photofrin (porf... | 6 Months - 18 Years | Medical College of Wisconsin | |
| Melphalan, Carboplatin, Mannitol, and Sodium Thiosulfate in Treating Patients With Recurrent or Progressive CNS Embryonal or Germ Cell Tumors | NCT00983398 | Central Nervous... Embryonal Tumor... Germ Cell Tumor Medulloblastoma Medulloepitheli... Primitive Neuro... Recurrent Child... Recurrent Malig... Recurrent Medul... Recurrent Primi... | Carboplatin Mannitol Melphalan Quality-of-Life... Questionnaire A... Sodium Thiosulf... | 18 Years - 45 Years | OHSU Knight Cancer Institute | |
| Adolescent and Young Adult Cancer Patients: Cognitive Toxicity on Survivorship (ACTS) | NCT03476070 | Breast Cancer Lymphoma Germ Cell Tumor Cognitive Impai... | 15 Years - 39 Years | National University of Singapore | ||
| MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors | NCT02076906 | Relapsed Pediat... Refractory Pedi... Rhabdomyosarcom... Ewing Sarcoma Osteosarcoma Neuroblastoma Wilms Tumor Hepatic Tumor Germ Cell Tumor Desmoid Tumor | Magnetic Resona... | - 30 Years | Children's National Research Institute | |
| Photodynamic Therapy (PDT) for Recurrent Pediatric Brain Tumors | NCT01682746 | Brain Tumor, Re... | Photofrin (porf... | 6 Months - 18 Years | Medical College of Wisconsin | |
| EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults | NCT03618381 | Pediatric Solid... Germ Cell Tumor Retinoblastoma Hepatoblastoma Wilms Tumor Rhabdoid Tumor Carcinoma Osteosarcoma Ewing Sarcoma Rhabdomyosarcom... Synovial Sarcom... Clear Cell Sarc... Malignant Perip... Desmoplastic Sm... Soft Tissue Sar... Neuroblastoma | second generati... second generati... | 1 Year - 30 Years | Seattle Children's Hospital | |
| Living After a Rare Cancer of the Ovary: Chronic Fatigue, Quality of Life and Late Effects of Chemotherapy | NCT03418844 | Germ Cell Tumor Sex Cord Stroma... Malignant Non-e... | Self-questionna... Cardiac, pulmon... | 18 Years - | Centre Francois Baclesse | |
| Study of Brentuximab Vedotin And Bevacizumab In Refractory CD-30 Positive Germ Cell Tumors | NCT02988843 | Germ Cell Tumor | Brentuximab Ved... Bevacizumab | 18 Years - | Masonic Cancer Center, University of Minnesota | |
| Living After a Rare Cancer of the Ovary: Chronic Fatigue, Quality of Life and Late Effects of Chemotherapy | NCT03418844 | Germ Cell Tumor Sex Cord Stroma... Malignant Non-e... | Self-questionna... Cardiac, pulmon... | 18 Years - | Centre Francois Baclesse | |
| Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies | NCT04308330 | Ewing Sarcoma Rhabdomyosarcom... Wilms Tumor Neuroblastoma Hepatoblastoma Germ Cell Tumor | Vorinostat | 1 Year - 30 Years | New York Medical College |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
